BTS Group Holdings Public Company Limited is a Thailand-based holding company engaged in the mass transit system. The Company operates elevated mass transit system business, which includes the network of BTS sky train and the bus rapid transit (BRT) system in Bangkok. The Company also is involved in other business, including media business, which focuses on managing all the advertising space on the original BTS sky train network; property business, which develops residential real estates and commercial real estates, and service business, which operates electronic money (e-money) services, hotel management services and construction managements service, as well as interior design. The Company's subsidiaries include Mak8 Company Limited, Nuvo Line Agency Company Limited and Primary Kitchen Company Limited.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
BTS report a net profit of Bt443m in 1QFY21, down 50% yoy. The results came in above our and consensus estimates. Advertising and property businesses took a big hit from COVID-19 while mass transit still posted a solid performance in 1QFY21. The recent share price rally over the last week was due to the anticipation of approval for Green Line concession extension. Maintain HOLD. Target price: Bt12.20. Entry price: Bt10.00.
KEY HIGHLIGHTS Results Amata Corporation (AMATA TB/BUY/Bt13.40/Target: Bt20.42) 2Q20: Decline in earnings within expectation. Bangkok Chain Hospital (BCH TB/BUY/Bt15.30/Target: Bt18.50) 2Q20: With managementâ€™s good strategy, earnings growth is expected to continue in 2H20 and well into 2021. BTS Group Holdings Public Company (BTS TB/HOLD/Bt10.90/Target: Bt12.20) 1QFY21: Earnings beat expectations on the back of mass transit business. Chularat Hospital Public Company Limited (CHG TB/BUY/Bt2.42/Target: Bt2.90) 2Q20: Earnings beat on upbeat profit margin.. CH Karnchang PCL (CK TB...
GREATER CHINA Results Ausnutria Dairy (1717 HK/BUY/HK$13.82/Target: HK$17.00): 2Q20: Results in line with slowdown being temporary. Li Ning (2331 HK/BUY/HK$31.55/Target: HK$35.00): 1H20: Results beat estimates spectacularly with unstoppable margin expansion. Upgrade to BUY. Pentamaster International (1665 HK/BUY/HK$1.96/Target: HK$2.26): 1H20: In line. After a washout 1H20, Pentamaster is now back to its full workforce run-rate with aggressive production ramp-up to make up for the shortfall. WuXi AppTec (2359 HK/BUY/HK$100.00/Target: HK$150.00): 1H20: Adjusted net profit up 28.9% yoy; China-ba...
BIDVEST GROUP (ZA), a company active in the Business Support Services industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis date September 22, 2020, the closing price was ZAR 135.50 and its expected value was estimated ...
The independent financial analyst theScreener just lowered the general evaluation of US ECOLOGY (US), active in the Waste & Disposal Services industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date September 22, 2020, the closing price was USD 31.57 and its target price was estimated at USD 27.22.
The independent financial analyst theScreener just changed two ratings for the qualification of UNITI GROUP (US), active in the Real Estate Investment Trusts industry. Its market behaviour has improved and can now be considered as moderately risky; its fundamental valuation receives an improved star rating and now shows 2 out of 4 stars. theScreener considers that these elements slightly improve the general evaluation, which passes therefore to Neutral. As of the analysis date September 22, 2020, the closing price was USD 9.80 and its expected value was estimated at USD 9.61.
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.